Global Influenza Vaccine Supply, Demand and Key Producers, 2026-2032
Description
The global Influenza Vaccine market size is expected to reach $ 14470 million by 2032, rising at a market growth of 5.4% CAGR during the forecast period (2026-2032).
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
Market Driver:The Influenza Vaccine market is driven by the rising global awareness of flu prevention and increasing government initiatives to promote vaccination programs. Seasonal influenza poses a significant public health burden, leading to hospitalizations and fatalities, particularly among high-risk populations such as the elderly, young children, and immunocompromised individuals. Governments and health organizations, including the WHO and CDC, actively support annual flu vaccination campaigns to reduce disease transmission. Additionally, advancements in vaccine technology, such as cell-based and recombinant influenza vaccines, are improving vaccine efficacy and production efficiency, further driving market growth.
Market Challenge:Despite its importance, the Influenza Vaccine market faces challenges related to vaccine hesitancy, manufacturing constraints, and viral mutations. Public skepticism regarding vaccine safety and effectiveness, fueled by misinformation, hampers vaccination rates in some regions. Additionally, influenza viruses undergo frequent genetic mutations, requiring annual vaccine updates and posing challenges in predicting dominant strains. Manufacturing influenza vaccines is also time-sensitive, as traditional egg-based production methods have limitations in scalability and response speed during pandemics. These factors can impact supply chain stability and overall vaccine accessibility.
Global key players of Pandemic Influenza Vaccine include Sanofi, CSL and GSK, etc. The top five players hold a share about 80%. North America is the largest market, has a share about 50%.
This report studies the global Influenza Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Influenza Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Influenza Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Influenza Vaccine total production and demand, 2021-2032, (M Units)
Global Influenza Vaccine total production value, 2021-2032, (USD Million)
Global Influenza Vaccine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (M Units), (based on production site)
Global Influenza Vaccine consumption by region & country, CAGR, 2021-2032 & (M Units)
U.S. VS China: Influenza Vaccine domestic production, consumption, key domestic manufacturers and share
Global Influenza Vaccine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (M Units)
Global Influenza Vaccine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (M Units)
Global Influenza Vaccine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (M Units)
This report profiles key players in the global Influenza Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, BCHT, Jiangsu GDK, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Influenza Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Influenza Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Influenza Vaccine Market, Segmentation by Type:
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Global Influenza Vaccine Market, Segmentation by Application:
6 Months to 3 Years
> 3 Years
Companies Profiled:
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Key Questions Answered:
1. How big is the global Influenza Vaccine market?
2. What is the demand of the global Influenza Vaccine market?
3. What is the year over year growth of the global Influenza Vaccine market?
4. What is the production and production value of the global Influenza Vaccine market?
5. Who are the key producers in the global Influenza Vaccine market?
6. What are the growth factors driving the market demand?
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
Market Driver:The Influenza Vaccine market is driven by the rising global awareness of flu prevention and increasing government initiatives to promote vaccination programs. Seasonal influenza poses a significant public health burden, leading to hospitalizations and fatalities, particularly among high-risk populations such as the elderly, young children, and immunocompromised individuals. Governments and health organizations, including the WHO and CDC, actively support annual flu vaccination campaigns to reduce disease transmission. Additionally, advancements in vaccine technology, such as cell-based and recombinant influenza vaccines, are improving vaccine efficacy and production efficiency, further driving market growth.
Market Challenge:Despite its importance, the Influenza Vaccine market faces challenges related to vaccine hesitancy, manufacturing constraints, and viral mutations. Public skepticism regarding vaccine safety and effectiveness, fueled by misinformation, hampers vaccination rates in some regions. Additionally, influenza viruses undergo frequent genetic mutations, requiring annual vaccine updates and posing challenges in predicting dominant strains. Manufacturing influenza vaccines is also time-sensitive, as traditional egg-based production methods have limitations in scalability and response speed during pandemics. These factors can impact supply chain stability and overall vaccine accessibility.
Global key players of Pandemic Influenza Vaccine include Sanofi, CSL and GSK, etc. The top five players hold a share about 80%. North America is the largest market, has a share about 50%.
This report studies the global Influenza Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Influenza Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Influenza Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Influenza Vaccine total production and demand, 2021-2032, (M Units)
Global Influenza Vaccine total production value, 2021-2032, (USD Million)
Global Influenza Vaccine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (M Units), (based on production site)
Global Influenza Vaccine consumption by region & country, CAGR, 2021-2032 & (M Units)
U.S. VS China: Influenza Vaccine domestic production, consumption, key domestic manufacturers and share
Global Influenza Vaccine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (M Units)
Global Influenza Vaccine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (M Units)
Global Influenza Vaccine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (M Units)
This report profiles key players in the global Influenza Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, BCHT, Jiangsu GDK, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Influenza Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Influenza Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Influenza Vaccine Market, Segmentation by Type:
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Global Influenza Vaccine Market, Segmentation by Application:
6 Months to 3 Years
> 3 Years
Companies Profiled:
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Key Questions Answered:
1. How big is the global Influenza Vaccine market?
2. What is the demand of the global Influenza Vaccine market?
3. What is the year over year growth of the global Influenza Vaccine market?
4. What is the production and production value of the global Influenza Vaccine market?
5. Who are the key producers in the global Influenza Vaccine market?
6. What are the growth factors driving the market demand?
Table of Contents
135 Pages
- 1 Supply Summary
- 2 Demand Summary
- 3 World Manufacturers Competitive Analysis
- 4 United States VS China VS Rest of the World
- 5 Market Analysis by Type
- 6 Market Analysis by Application
- 7 Company Profiles
- 8 Industry Chain Analysis
- 9 Research Findings and Conclusion
- 10 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
